Delivery Order SPE2DB24D1205-SPE2DB25FCYFQ
- Not listed
- This is a $3,226.63 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568639733 ADDYI 100 MG TABLET UU 30S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a $2,775.75 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ADDYI 100 MG TABLET UU 30S, a medication, with a completion date of April 2, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADDYI 100 MG TABLET UU 30S, a pharmaceutical product, with a firm fixed price ceiling value of $2,903.61 and a performance period through July 1, 2025. The contract was awarded on June 30, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,624.46, is for the delivery of ADDYI 100 MG TABLET with a completion date of June 17, 2025. The contract is a firm fixed-price delivery order, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADDYI 100 MG TABLET in units of 30, with a firm fixed price of $1,935.74 and a performance period through June 18, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,764.18 firm fixed-price delivery order is for the supply of ADDYI 100 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,436.06 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565333877 ADDYI 100 MG TABLET UU 30S. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military...
- The Defense Logistics Agency awarded a $1,935.74 delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (30-count units) under a firm fixed price contract type. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025. This contract represents a non-set-aside, competitively awarded delivery order, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $3,436.06, is for the delivery of ADDYI 100 MG TABLET UU 30S, a pharmaceutical product. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,267.49 firm fixed-price delivery order is for the supply of ADDYI 100 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 17, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYFQDelivery Order
This is a $6,851.33 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568701565 - ADDYI 100 MG TABLET UU 30S, a pharmaceutical product. The contract is not set aside and was awarded on July 2, 2025, with a completion date of July 3, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order contract is likely part of the broader IDC, allowing the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 7/2/25 |